From today, the Australian government will expand Pharmaceutical Benefit Scheme (PBS) access to the drug Keytruda for three additional types of cancer. This is part of a broader shift away from cancer ...

Merck (NYSE:MRK) entered an exclusive global license agreement with SciBrunch Therapeutics to develop oral KRAS G12D ...

Commercial orbital laboratories could extend proven microgravity research, but regulation and return logistics remain unresolved.

Morgan Stanley 24th Annual Global Healthcare Conference September 14, 2026 10:00 AM EDTCompany ParticipantsStephen Hoge ...

I found a lump in my left breast.After undergoing a needle biopsy and MRI at the general hospital, Triple-negative breast ...

By Akash Sriram and Mariam Sunny Sept 17 (Reuters) - As the International Space Station nears the end of its operational life ...

Moderna's upside hinges on Intismeran’s ability to scale across multiple tumor types, not just melanoma. Learn why MRNA stock is a strong buy.

Cancer vaccines show promise for melanoma, pancreatic, and colorectal cancer in Peoria and beyond, with new mRNA trials and ...

Skepticism about the government’s pandemic response is one thing. Writing off mRNA vaccine technology is another.

The future is about personalised medicine, targeted therapies, immunotherapy, and increasingly precise drug delivery working together” ...

Decisions around trial design, regulatory strategy, and manufacturing planning ultimately determine whether a therapy reaches patients.